首頁 > 市場調查報告書 > 醫療設備

整形外科

市場調查報告書

商品編碼

1643890

全球骨科支架和支架、鑄件和夾板市場 - 2025-2033

Global Orthopedic Braces & Support, Casting & Splints Market - 2025-2033

出版日期: 2025年01月27日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024年，全球骨科支架和支撐、鑄件和夾板市場達到52億美元，預計到2033年將達到92億美元，2025-2033年預測期間複合年成長率為6.4%。

矯形支架和支架、鑄件和夾板是在損傷恢復、術後復健或慢性病管理期間支撐、保護和穩定肌肉骨骼結構的裝置。矯形支架和支架可透過為關節、韌帶和肌肉提供有針對性的壓縮和穩定性來減輕疼痛、改善活動能力並防止進一步受傷。石膏和夾板可固定骨折和扭傷，使其正常癒合。該市場的成長是由人口老化、運動傷害增加、關節炎等慢性病以及新興地區醫療保健覆蓋範圍擴大所推動的。向非侵入性治療和家庭護理的轉變也增加了對創新骨科解決方案的需求。

市場動態：

驅動程式和限制

科技進步的崛起

技術進步正在徹底改變骨科支架和支撐、鑄造和夾板市場，改善患者的治療效果和耐用性。碳纖維和先進複合材料等輕質材料使這些設備更加方便用戶使用和有效。 3D 列印技術徹底改變了客製化方式，可以根據患者的特定解剖結構客製化精確的支架和夾板。具有感測器和物聯網功能的智慧骨科設備不斷湧現，可以即時監控患者的活動能力、癒合進度和治療依從性。

此外，透氣和抗菌布料增強了舒適性和衛生性，鼓勵在慢性病患者中長期使用。數位成像和建模技術簡化了設計和製造流程，減少了交貨時間和生產成本。這些進步正在擴大可近性，特別是在家庭照護環境和服務不足的地區。

假冒或劣質產品的可用性

全球骨科支架和支架、鑄件和夾板市場中的假冒或劣質產品是一項重大挑戰，影響患者的治療結果和市場成長。這些不合格產品通常以較低價格出售，不符合安全性和功效標準，可能會導致不適、支援不足或進一步傷害。假冒產品削弱了消費者對骨科器械的信任，使患者和醫療保健提供者不願採用它們。這個問題在價格敏感且不受監管的市場中尤其普遍。信譽良好的製造商面臨來自劣質替代品的競爭，這會影響收入，並需要加強對利害關係人進行有關不合規產品的教育。假冒商品的存在凸顯了更嚴格的監管執法和宣傳活動的必要性。

Alcare Co., Ltd
Bauerfeind Ag
Bird and Cronin, Inc.
Breg, Inc.
Bsn Medical
DEROYAL INDUSTRIES, INC.
DJO FINANCE LLC
MEDI GMBH & CO. KG
Ossur Hf
Similar data will be provided for each market player.
主動裝甲
- 管道產品說明
- 產品關鍵績效指標 (KPI)
- 主要活動
- 市場進入時間表
- 產品滲透率
- 銷售估算與預測
演員21
梅迪
真實生活
將為每個市場參與者提供類似的資料。

第 12 章：附錄

簡介目錄

Product Code: MD9056

The global orthopedic braces & support, casting & splints market reached US$ 5.20 billion in 2024 and is expected to reach US$ 9.20 billion by 2033, growing at a CAGR of 6.4% during the forecast period 2025-2033.

The orthopedic braces & support, casting & splints are devices that supports, protects, and stabilizes musculoskeletal structures during injury recovery, post-surgical rehabilitation, or chronic condition management. Orthopedic braces and supports alleviate pain, improve mobility, and prevent further injury by providing targeted compression and stabilization for joints, ligaments, and muscles. Casting and splints immobilize fractures and sprains for proper healing. The market's growth is driven by an aging population, rising sports injuries, chronic conditions like arthritis, and expanding healthcare access in emerging regions. The shift towards non-invasive treatments and home-based care has also increased demand for innovative orthopedic solutions.

Market Dynamics: Drivers & Restraints

Rise in the Technological Advancements

Technological advancements are revolutionizing the orthopedic braces & support, casting & splints market, improving patient outcomes and durability. lightweight materials like carbon fiber and advanced composites have made these devices more user-friendly and effective. 3Dprinting technology has revolutionized customization, allowing for precise braces and splints tailored to individual patient anatomies. smart orthopedic devices with sensors and iot capabilities are emerging, providing real-time monitoring of patient mobility, healing progress, and therapy compliance.

Moreover breathable and antimicrobial fabrics have enhanced comfort and hygiene, encouraging prolonged use in chronic conditions. digital imaging and modeling technologies have streamlined design and manufacturing processes, reducing lead times and production costs. these advancements are expanding accessibility, particularly in home-care settings and underserved regions.

Availability of Counterfeit or Low-Quality Products

Counterfeit or low-quality products in the Global Orthopedic Braces & Support, Casting & Splints Market are a significant challenge, affecting patient outcomes and market growth. These substandard products, often sold at lower prices, fail to meet safety and efficacy standards, potentially causing discomfort, inadequate support, or further injury. Counterfeit products dilute consumer trust in orthopedic devices, making patients and healthcare providers hesitant to adopt them. This issue is particularly prevalent in price-sensitive and unregulated markets. Reputable manufacturers face competition from inferior alternatives, impacting revenue and requiring increased efforts to educate stakeholders about non-compliant products. The presence of counterfeit items highlights the need for stricter regulatory enforcement and awareness campaigns.

Segment Analysis

The global orthopedic braces & support, casting & splints market is segmented based on product type, type, application, end user and region.

Product Type:

Knee Braces and supports segment is expected to dominate the Orthopedic Braces & Support, Casting & Splints market share

The knee braces and supports segment holds a major portion of the orthopedic braces & support, casting & splints market share and is expected to continue to hold a significant portion of the orthopedic braces & support, casting & splints market share during the forecast period.

Knee braces and supports are crucial in the Global Orthopedic Braces & Support, Casting & Splints Market, addressing conditions like osteoarthritis, sports injuries, post-surgical rehabilitation, and chronic knee pain. With the increasing prevalence of knee osteoarthritis among the aging population and sports-related injuries among younger individuals, demand for these devices has surged. Innovations like lightweight materials, adjustable designs, and advanced compression technologies have improved patient comfort and treatment efficacy. Customizable and 3D-printed knee braces are gaining traction, offering superior fit and support. The growing awareness of preventive care has encouraged the adoption of knee supports by athletes and fitness enthusiasts. Telemedicine and home-based rehabilitation programs further support the use of these devices.

For instance, in May 2024, McDavid, a leading sports medicine and protective gear company, has launched new NRG knee braces featuring Spring Hinge Joint Assist technology. These braces, available in the NRG Over Knee Wrap and NRG Knee Brace, reduce knee stress by up to 25% by storing energy when flexed and rebounding with the body's natural movement. The lightweight construction of the spring hinge, made with a high-strength polymer, offloads stress from muscles and knees, making them ideal for those dealing with joint instabilities, sprains, strains, or post-surgery rehabilitation.

Application:-

Osteoarthirits segment is the fastest-growing segment in orthopedic braces & support, casting & splints market share

The osteoarthritis segment is the fastest-growing segment in the orthopedic braces & support, casting & splints market share and is expected to hold the market share over the forecast period.

Osteoarthritis, a prevalent chronic condition affecting Billions, particularly the aging population, drives the global Orthopedic Braces & Support, Casting & Splints Market. These devices provide non-invasive solutions to manage symptoms, delay disease progression, and reduce surgical intervention needs. Advancements in lightweight materials and adjustable designs have made braces more comfortable for prolonged use. The focus on personalized care has led to the development of custom-fit and 3D-printed braces tailored to individual anatomies. The growing awareness of early management and rising prevalence due to sedentary lifestyles and obesity continue to drive the market forward.

For instance, according to recent studies in NCBI reveal that over 20 million U.S. patients suffer from osteoarthritis, and nearly 2,40,000 children suffer from arthritis. This will increase demand and product penetration in the region, driven by easy access to advanced raw materials and qualified healthcare providers in countries like Canada and the U.S.

Geographical Analysis

North America is expected to hold a significant position in the Orthopedic Braces & Support, Casting & Splints market share

North America holds a substantial position in the orthopedic braces & support, casting & splints market and is expected to hold most of the market share due to its advanced healthcare infrastructure and high healthcare expenditure. The rising prevalence of musculoskeletal disorders, such as arthritis and osteoporosis, is driving demand. North America's leading companies invest heavily in R&D, leading to frequent innovations and product launches. The focus on sports and fitness activities has increased awareness and adoption of orthopedic supports for injury prevention.

For instance, in January 2024, Enovis DJO has launched its DonJoy Roam OA knee brace, designed to alleviate pain and improve stability in patients with osteoarthritis or other knee pain and instability. The innovative brace uses unloader technology to shift weight away from the affected knee, promoting dynamic mobility and allowing patients to maintain or increase activity.

Europe is growing at the fastest pace in the Orthopedic Braces & Support, Casting & Splints market

Europe holds the fastest pace in the orthopedic braces & support, casting & splints market and is expected to hold most of the market share due to aging population and increasing chronic conditions. The region benefits from robust government healthcare programs, subsidized treatment options, and reimbursement frameworks. The demand for non-invasive treatments and rehabilitation is also growing. Technological adoption, such as 3D-printed devices and smart orthopedic solutions, is also driving market growth. Additionally, rising awareness of workplace ergonomics and preventive healthcare contributes to the market.

For instance, in 2024, the prevalence of various types of arthritis in the UK is estimated to be around 10 million, with 5.4 million people suffering from knee and hip OA, 450,000 with Rheumatoid Arthritis, and 190,000 with Psoriatic Arthritis. Over 20 million people, including 11.6 million women and 8.7 million men, live with MSK, accounting for a third of the population.

Competitive Landscape

The major global players in the orthopedic braces & support, casting & splints market include 3M Company, Alcare Co., Ltd, Bauerfeind Ag, Bird and Cronin, Inc, Breg, Inc, Bsn Medical, DEROYAL INDUSTRIES, INC, DJO FINANCE LLC, MEDI GMBH & CO. KG, Ossur Hf and among others.

Key Developments

In January 2024, UNFO Med has introduced a corrective foot brace to treat newborn foot conditions, including metatarsus adductus (MTA). The non-invasive device, developed by UNFO Med founder and R&D director Dr Izak Daizade, is worn below the ankle to correct three-dimensional anatomic deformities and misalignments in infants' foot structures. The UNFO system, the result of seven years of research, has successfully treated over 15,000 patients with a 95% success rate.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global orthopedic braces & support, casting & splints market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Application & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Type
3.3. Snippet by Application
3.4. Snippet by End User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rise in the Technological Advancements
- 4.1.2. Restraints
  - 4.1.2.1. Availability of Counterfeit or Low-Quality Products
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Product Type

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 6.1.2. Market Attractiveness Index, By Product Type
6.2. Knee Braces and supports*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Facial Braces & Supports
6.4. Hand & Wrist Braces and Supports
6.5. Elbow Braces and Supports
6.6. Shoulder Braces and Supports
6.7. Back, Hip, and Spine Braces and Supports
6.8. Foot walkers and orthoses
6.9. Ankle braces and supports

7. By Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 7.1.2. Market Attractiveness Index, By Type
7.2. Soft & Elastic Braces and Supports*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Hard Braces and Supports
7.4. Hinged Braces and Supports

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 8.1.2. Market Attractiveness Index, By Application
8.2. Osteoarthritis*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Ligament Injury
8.4. Preventive Care
8.5. Compression Therapy
8.6. Post-Operative Rehabilitation
8.7. Others

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Diagnostic Centers
9.4. Ambulatory Surgical Centers
9.5. Research Institutes
9.6. Home Healthcare

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.7.1. U.S.
  - 10.2.7.2. Canada
  - 10.2.7.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. U.K.
  - 10.3.7.3. France
  - 10.3.7.4. Spain
  - 10.3.7.5. Italy
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.7.1. Brazil
  - 10.4.7.2. Argentina
  - 10.4.7.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.7.1. China
  - 10.5.7.2. India
  - 10.5.7.3. Japan
  - 10.5.7.4. South Korea
  - 10.5.7.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

Key Market Players

12.1. 3M Company*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio
  - 12.1.2.1. Product Description
  - 12.1.2.2. Product Key Performance Indicators (KPIs)
  - 12.1.2.3. Historic and Forecasted Product Sales
  - 12.1.2.4. Product Sales Volume
- 12.1.3. Financial Overview
  - 12.1.3.1. Company Revenue's
  - 12.1.3.2. Geographical Revenue Shares
  - 12.1.3.3. Revenue Forecasts
- 12.1.4. Key Developments
  - 12.1.4.1. Mergers & Acquisitions
  - 12.1.4.2. Key Product Development Activities
  - 12.1.4.3. Regulatory Approvals etc.
- 12.1.5. SWOT Analysis
12.2. Alcare Co., Ltd
12.3. Bauerfeind Ag
12.4. Bird and Cronin, Inc.
12.5. Breg, Inc.
12.6. Bsn Medical
12.7. DEROYAL INDUSTRIES, INC.
12.8. DJO FINANCE LLC
12.9. MEDI GMBH & CO. KG
12.10. Ossur Hf
Similar data will be provided for each market player.

Emerging Market Players

12.11. ActiveArmor*
- 12.11.1. Pipeline Products Description
- 12.11.2. Product Key Performance Indicators (KPIs)
- 12.11.3. Key Activities
- 12.11.4. Market Entry Timelines
- 12.11.5. Product Penetration Rate
- 12.11.6. Sales Estimation and Projections
12.12. CAST21
12.13. Medi
12.14. Truelife
Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE